Dressler syndrome and post-cardiac injury syndrome
Late pericarditis after MI, cardiac surgery or procedures; the ESC 2025 diagnostic definition and the older 2-of-5 rule, telling it from early post-infarct pericarditis and rupture, high-dose aspirin plus colchicine, and colchicine prophylaxis before cardiac surgery.
Tier 2Condition
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- Post-cardiac injury syndrome (PCIS) is the ESC umbrella for pericarditis that follows injury to the heart: Dressler syndrome after MI, post-pericardiotomy syndrome after cardiac surgery, and post-traumatic pericarditis, which today is mostly iatrogenic (PCI perforation, pacemaker leads, AF ablation).
- It is immune-mediated. The latent period of weeks, the response to anti-inflammatory drugs and the tendency to recur all point that way.
- Dressler syndrome is now under 1% of MIs in the reperfusion era, mostly after large infarcts or late reperfusion. Post-pericardiotomy syndrome is far more common, roughly 10 to 30% after cardiac surgery.
Loading the rest of the note…
Finished reading?
Sources
- Schulz-Menger J, Collini V, Gröschel J et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J 2025;46(40):3952-4041. doi:10.1093/eurheartj/ehaf192European Society of Cardiology, 2025
- Imazio M, Tomat M. Evaluation and management of post-cardiotomy syndrome. Methodist DeBakey Cardiovasc J 2026;22(2):27-40. doi:10.14797/mdcvj.1783Methodist DeBakey Cardiovascular Journal, 2026
- Brieger D, Cullen L, Briffa T et al. National Heart Foundation of Australia and CSANZ: Comprehensive Australian clinical guideline for diagnosing and managing acute coronary syndromes 2025. Heart Lung Circ 2025;34(4):309-397. doi:10.1016/j.hlc.2025.02.102AU/NZNational Heart Foundation of Australia and CSANZ (Heart, Lung and Circulation), 2025
- Therapeutic Guidelines: Cardiovascular (pericarditis)AU/NZTherapeutic Guidelines Ltd
- Imazio M et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation (COPPS-2). JAMA 2014;312:1016-23JAMA, 2014
- Meurin P et al. Colchicine for postoperative pericardial effusion: a multicentre, double-blind, randomised controlled trial (POPE-2). Heart 2015;101:1711-6Heart, 2015
- Adler Y, Charron P, Imazio M et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J 2015;36(42):2921-64. doi:10.1093/eurheartj/ehv318European Society of Cardiology, 2015
- Brilinta (ticagrelor) prescribing information: aspirin maintenance dose and the PLATO aspirin-dose analysisAstraZeneca (DailyMed), 2026
- Colgout (colchicine) Australian product informationAU/NZTherapeutic Goods Administration, 4 June 2026
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback